Cargando…
The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery
The Port Delivery System with ranibizumab (PDS) is an innovative intraocular drug delivery system designed for the continuous delivery of ranibizumab into the vitreous for 6 months and beyond. The PDS includes an ocular implant, a customized formulation of ranibizumab, and four dedicated ancillary d...
Autores principales: | Ranade, Shrirang V., Wieland, Mark R., Tam, Tammy, Rea, Jennifer C., Horvath, Judit, Hieb, Aaron R., Jia, Weitao, Grace, Lori, Barteselli, Giulio, Stewart, Jay M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067954/ https://www.ncbi.nlm.nih.gov/pubmed/35499315 http://dx.doi.org/10.1080/10717544.2022.2069301 |
Ejemplares similares
-
EVALUATION OF SURGICAL FACTORS AFFECTING VITREOUS HEMORRHAGE FOLLOWING PORT DELIVERY SYSTEM WITH RANIBIZUMAB IMPLANT INSERTION IN A MINIPIG MODEL
por: Bantseev, Vladimir, et al.
Publicado: (2020) -
Ranibizumab port delivery system: a clinical perspective
por: Eichenbaum, David A, et al.
Publicado: (2022) -
Ranibizumab port delivery system in neovascular age-related macular degeneration
por: Chandrasekaran, Priya R., et al.
Publicado: (2022) -
Therapeutic Potential of the Ranibizumab Port Delivery System in the Treatment of AMD: Evidence to Date
por: Chen, Eric R, et al.
Publicado: (2020) -
Virtual Reality Becomes a Reality for Ophthalmologic Surgical Clinical Trials
por: Pieramici, Dante J., et al.
Publicado: (2020)